Related Experiment Video
Updated: Aug 8, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Antibiotic therapy in serious infectious states]
1Service de réanimation polyvalente, fondation hôpital Saint-Joseph, 185, rue Raymond-Losserand, 75674 Paris cedex 14, France. jcarlet@hopital-saint-joseph.org
Medecine Et Maladies Infectieuses
|May 16, 2006
Summary
Tailoring antibiotic strategies is crucial for severe sepsis management to reduce high mortality rates. Appropriate empiric therapy depends on timely administration, bacterial resistance, and antibiotic properties.
Area of Science:
- Infectious Diseases
- Pharmacology
- Critical Care Medicine
Background:
- Severe sepsis is a life-threatening condition associated with high mortality.
- Effective management necessitates a precise and individualized antibiotic approach.
- Empiric antibiotic therapy is the initial treatment before pathogen identification.
Purpose of the Study:
- To emphasize the critical factors influencing the appropriateness of empiric antibiotic therapy in severe sepsis.
- To highlight the importance of adapting treatment strategies to individual patient cases.
Main Methods:
- Review of key factors influencing empiric antibiotic selection in severe sepsis.
- Analysis of the roles of administration delay, bacterial resistance, and antimicrobial pharmacokinetics/pharmacodynamics (PK/PD).
Main Results:
- The appropriateness of empiric therapy is significantly impacted by the time to antibiotic administration.
- Bacterial resistance patterns are a critical determinant of treatment efficacy.
- The inherent kinetic and dynamic properties of antibiotics play a vital role in successful outcomes.
Conclusions:
- Individualized antibiotic strategies are essential for optimizing severe sepsis treatment.
- Timely administration, consideration of resistance profiles, and understanding antibiotic PK/PD are paramount for effective empiric therapy.
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...